Market capitalization is the total value the stock market puts on a company: its share price multiplied by the number of shares outstanding. Each point here is the share count reported in a filing multiplied by the closing price on that filing date, adjusted for later stock splits, so the history moves when a new filing arrives rather than with each day's trading. A larger market cap means investors collectively value the company more highly; by itself it says nothing about profit or debt. Annual points keep the latest observation in each calendar year.
BIOMARIN PHARMACEUTICAL INC market cap for the quarter ending 2026-07-28 was $12.02B, a 7.66% increase year-over-year.
BIOMARIN PHARMACEUTICAL INC market cap for the quarter ending 2026-06-30 was $11.08B, a 4.95% increase year-over-year.
BIOMARIN PHARMACEUTICAL INC market cap for the quarter ending 2026-04-23 was $10.44B, a 14.04% decline year-over-year.
BIOMARIN PHARMACEUTICAL INC market cap for the quarter ending 2026-03-31 was $10.92B, a 19.44% decline year-over-year.
BIOMARIN PHARMACEUTICAL INC market cap for fiscal 2026 was $12.02B.
BIOMARIN PHARMACEUTICAL INC market cap for fiscal 2025 was $11.43B, a 8.86% decline from fiscal 2024.
BIOMARIN PHARMACEUTICAL INC market cap for fiscal 2024 was $12.54B, a 31.05% decline from fiscal 2023.
BIOMARIN PHARMACEUTICAL INC market cap for fiscal 2023 was $18.18B, a 5.66% decline from fiscal 2022.